Staff Reports
The latest Washington theater involves three short, loud acts: a citizen petition by former FDA chief David Kessler, a leaked “Make America Healthy Again” (MAHA) strategy memo, and a draft HHS letter from Secretary Robert F. Kennedy Jr. that praises Kessler’s work but stops short of real fire. Together those documents are the real story — not the slogans. They tell us whether MAHA will be a bold regulatory push or just another White House headline that quiets the base and spooks voters and business owners.
Kessler’s petition: a legal wedge against “GRAS” ingredients
The petition is no rhetorical flourish. It asks the FDA to re-examine the “generally recognized as safe” (GRAS) status of many refined carbohydrates used in ultra-processed foods. If the agency accepts that argument, whole product lines could face new premarket reviews, reformulation, and legal fights. That’s a big deal for food makers, farmers, and families who already struggle with higher grocery bills.
HHS’s draft letter: praise without teeth — and activists are furious
The HHS draft praised Kessler’s petition but did not set deadlines or force action. The White House hasn’t officially sent it. Predictably, MAHA activists called it “too timid.” They wanted immediate bans and sweeping rules. Conservatives should listen: a cautious, measured approach beats a panic-driven regulatory campaign that would raise prices and invite litigation. The question now is whether the administration will follow the law and public process — or quietly let political hunger for headlines turn into heavy-handed regulation later.
Why this matters to taxpayers, producers, and Congress
Regulatory experiments with big private-sector knock-on effects come with costs — and not just in grocery prices. Lawyers, recalls, and compliance bills funnel money away from families and small businesses. Meanwhile, Washington still faces a massive federal debt problem that eats policy bandwidth and squeezes future growth. If the administration wants to end unhealthy outcomes, use common-sense steps: target clear harms, protect due process, and avoid punitive rules that punish everyday Americans to score political points.
Watch the FDA docket and the White House closely. If the draft letter becomes policy, expect fights in court and on Capitol Hill. If it stays a draft, expect outraged activists and muted industry relief. Either way, voters deserve honesty: don’t promise radical change to win applause, then slip through rules that raise costs without fixing the root causes. And if Washington is looking for priorities, try tackling the “debt blob” before cooking up crusades that make life harder at the checkout line.
